# Double-Blind Placebo-Controlled Trial of Riluzole in Pediatric Bipolar Disorder

> **NCT00805493** · PHASE2 · TERMINATED · sponsor: **National Institute of Mental Health (NIMH)** · enrollment: 6 (actual)

## Conditions studied

- Bipolar Disorder
- Anxiety Disorders
- Bipolar Affective Disorder
- Bipolar Depression

## Interventions

- **DRUG:** Riluzole

## Key facts

- **NCT ID:** NCT00805493
- **Lead sponsor:** National Institute of Mental Health (NIMH)
- **Sponsor class:** NIH
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2008-11
- **Primary completion:** 2012-06
- **Final completion:** 2012-06
- **Target enrollment:** 6 (ACTUAL)
- **Why stopped:** Insufficient recruitment of participants
- **Last updated:** 2017-09-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00805493

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00805493, "Double-Blind Placebo-Controlled Trial of Riluzole in Pediatric Bipolar Disorder". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT00805493. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*